Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 4Lymphoma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Lymphoma, T-Cell 3Recurrence 2Hereditary Sensory and Autonomic Neuropathies 2Hematologic Neoplasms 2Sezary Syndrome 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Plasma Cell 1Mycosis Fungoides 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Prolymphocytic, T-Cell 1Leukemia, Lymphoid 1Leukemia, Large Granular Lymphocytic 1Leukemia 1Hodgkin Disease 1Enteropathy-Associated T-Cell Lymphoma 1

Interventions

ibrutinib 3Vincristine 2Methotrexate 2tozasertib 1thymoglobulin 1romiplostim 1pembrolizumab 1pegaspargase 1palbociclib 1obinutuzumab 1lucatumumab 1fludarabine 1fenebrutinib 1enzastaurin 1duvelisib 1Receptors, Chimeric Antigen 1Prednisone 1Prednisolone 1Hydrocortisone 1Hu-Mik-beta-1 monoclonal antibody 1Doxorubicin 1Dasatinib 1Cytarabine 1Cyclophosphamide 1Busulfan 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Leukemia, Lymphoid × duvelisib × Clear all
NCT05065866 2025-12-04

Duvelisib in Combination With BMS-986345 in Lymphoid Malignancy

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
14 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Lymphoid, Lymphoma, Non-Hodgkin, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡